Le Lézard
Classified in: Health, Business
Subjects: NPT, SVY, AVO

Action needed now - new campaign highlights crisis in home and community support sector


Ontario Community Support Association launches a campaign clearly outlining sector struggle to continue supporting vulnerable Ontarians
 

TORONTO, March 9, 2022 /CNW/ - Following the recent release of its member survey results, which convey the bleak state of Ontario's home and community support services sector, the Ontario Community Support Association (OCSA) has launched a campaign to raise awareness of a sector in crisis.

After releasing data from their 2021 member survey that conveys staff vacancy rates have nearly tripled from 2020 to 2021, OCSA is now outlining the dire staffing impacts, significant wage disparity and a system in desperate need of funding in shareable infographics as part of its awareness campaign.

OCSA is a member organization representing more than 220 agencies across Ontario that together support more than one million Ontarians in home and community care services. The sector cares for diverse clients of all ages across the province, with a range of care needs including vulnerable clients on dialysis and home ventilators. Services include nursing care, personal care, rehabilitation, adult day programs, supportive housing/assisted living programs, Meals on Wheels, transportation, transitional care and much more.

"We are now seeing Ontarians unable to access care due to extreme staffing shortages," says Deborah Simon, OCSA CEO. "We desperately need funding and a comprehensive strategy that includes wage parity across the health care sector."

OCSA is calling on Ontarians to visit their website to learn more and to take action. This includes sharing infographics on social media to raise awareness, writing letters to MPPs, reading client stories to learn more about home and community care and sharing personal home and community care support stories to help put a face on the diverse people in need of these services.

OCSA member organizations rely on government support and fundraising. The growing staff shortages are leading to longer waitlists and at the current trajectory, will lead to the cancellation of programs or services. This will mean increased caregiver burden as well as added pressures on long-term care and hospitals across Ontario.

"We are committed to shining a bright light on a desperate situation that needs action now," adds Simon. "These issues must be urgently addressed if we expect to have a health care safety net that keeps vulnerable Ontarians safe at home and in the community."

About OCSA

Celebrating our 30th anniversary, the Ontario Community Support Association (OCSA) represents over 220 not-for-profit organizations that provide home care and community support services to over one million Ontarians. Our members help seniors and people with disabilities live independently in their own homes and communities for as long as possible. These proactive and cost-effective services improve quality of life and prevent unnecessary hospitalizations, emergency room visits and premature institutionalization. They are the key to a sustainable health care system for Ontario. For more information, visit www.ocsa.on.ca or @OCSATweets.

SOURCE Ontario Community Support Association


These press releases may also interest you

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...



News published on and distributed by: